OSCR

Glial Scar-Targeted Modification of Hepatocyte Growth Factor-Derived Peptide for Spinal Cord Injury Therapeutic Repair.

Overview

Authors: Yuzhe Wu1,2, Jingwei Shi3, Ruize Miao1,2, Linyi Xiang1,2, Jiacheng Zhang1,2, Weiyi Chi4, Yuheng Zhang5, Yibo Geng6, Xiong Cai7, Yun Shu1,2, Jiayi Zhao1,2, Junsheng Zhu1,2, Xiaoqiong Jiang8, Haojie Zhang9, Zhenglin Li3,8,10, Xiangyang Wang1,2, Sunren Sheng1,2, Chenchen Zhu11, Jianjun Qi12, Jian Xiao1,3,8,10, Kailiang Zhou1,2,3
  1. Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325027, China
  2. Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou 325027, China
  3. Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315300, China
  4. The First Clinical Medical College (School of Information and Engineering), Wenzhou Medical University, Wenzhou 325035, China
  5. The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325027, China
  6. Department of Orthopaedics, Tangdu Hospital, The Air Force Medical University, Xi’an 710038, China
  7. School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou 325000, China
  8. Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China
  9. Department of Orthopedics, Xuanwu Hospital of Capital Medical University, Beijing 100053, China
  10. Department of Wound Repair, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China
  11. Department of Ophthalmology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China
  12. Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu 241001, China
Journal: Biomaterials research, volume 30, article 0431
Dates: received 26 June 2026; accepted 25 September 2026; published online 27 October 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.34133/bmr.0431 · PMID 42947949 · PMCID PMC13710766 · OpenAlex W7220428103
Open access: gold, a free copy (OpenAlex)
Categories: other condition (population), clinical / translational (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Machine learning
Topic: Spinal Cord Injury Research (Clinical Neurology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 50 references in the paper

Abstract

Spinal cord injury (SCI) causes irreversible neural damage and functional impairment. H-RN is a short peptide originating from the kringle 1 domain of hepatocyte growth factor. Despite its efficacy in inhibiting inflammatory responses, the precise neuroprotective mechanisms of the peptide H-RN in SCI remain unclear. The short peptide CAQK can target the lesion epicenter of SCI. To explore the role of the peptide H-RN in SCI and address the numerous challenges faced by conventional drug therapies, this study developed a synthetic peptide, CAQK-H-RN. Our results revealed that CAQK-H-RN could cross the blood–spinal cord barrier, precisely target the SCI region, and increase drug accumulation at the injury site, thereby reducing glial scar formation, decreasing motor neuron death, and enhancing functional recovery after SCI. RNA sequencing was performed to explore the molecular mechanisms of CAQK-H-RN in SCI, which revealed that CAQK-H-RN inhibited pyroptosis and ameliorated lysosomal membrane permeabilization (LMP)-induced autophagic flux disorders in neurons after SCI. Additionally, CAQK-H-RN alleviated LMP by suppressing acid sphingomyelinase activity through the p38 mitogen-activated protein kinase/Ets-like protein-1 (Elk-1)/early growth response protein 1 (Egr-1) signaling cascade and subsequently enhanced autophagy, thereby mitigating neuronal death. This intravenous therapeutic system centered on the synthetic peptide CAQK-H-RN contributes to the functional restoration of SCI, which may be clinically applicable to spinal cord repair.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability

The data that support the findings of this study are available from the corresponding authors upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 October 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 21 authors, 1 funder, 48 references.

Cite

This paper

Wu, Y., Shi, J., Miao, R., Xiang, L., Zhang, J., Chi, W., Zhang, Y., Geng, Y., Cai, X., Shu, Y., Zhao, J., Zhu, J., Jiang, X., Zhang, H., Li, Z., Wang, X., Sheng, S., Zhu, C., Qi, J., . . . Zhou, K. (2026). Glial Scar-Targeted Modification of Hepatocyte Growth Factor-Derived Peptide for Spinal Cord Injury Therapeutic Repair. Biomaterials research, 30, 0431. https://doi.org/10.34133/bmr.0431

BibTeX

@article{wu2026glial,
author = {Wu, Yuzhe and Shi, Jingwei and Miao, Ruize and Xiang, Linyi and Zhang, Jiacheng and Chi, Weiyi and Zhang, Yuheng and Geng, Yibo and Cai, Xiong and Shu, Yun and Zhao, Jiayi and Zhu, Junsheng and Jiang, Xiaoqiong and Zhang, Haojie and Li, Zhenglin and Wang, Xiangyang and Sheng, Sunren and Zhu, Chenchen and Qi, Jianjun and Xiao, Jian and Zhou, Kailiang},
title = {{Glial Scar-Targeted Modification of Hepatocyte Growth Factor-Derived Peptide for Spinal Cord Injury Therapeutic Repair}},
journal = {Biomaterials research},
year = {2026},
month = oct,
volume = {30},
pages = {0431},
publisher = {AAAS Science Partner Journal Program},
issn = {1226-4601},
doi = {10.34133/bmr.0431},
url = {https://doi.org/10.34133/bmr.0431},
pmid = {42947949},
pmcid = {PMC13710766}
}

RIS

TY - JOUR
AU - Wu, Yuzhe
AU - Shi, Jingwei
AU - Miao, Ruize
AU - Xiang, Linyi
AU - Zhang, Jiacheng
AU - Chi, Weiyi
AU - Zhang, Yuheng
AU - Geng, Yibo
AU - Cai, Xiong
AU - Shu, Yun
AU - Zhao, Jiayi
AU - Zhu, Junsheng
AU - Jiang, Xiaoqiong
AU - Zhang, Haojie
AU - Li, Zhenglin
AU - Wang, Xiangyang
AU - Sheng, Sunren
AU - Zhu, Chenchen
AU - Qi, Jianjun
AU - Xiao, Jian
AU - Zhou, Kailiang
TI - Glial Scar-Targeted Modification of Hepatocyte Growth Factor-Derived Peptide for Spinal Cord Injury Therapeutic Repair
T2 - Biomaterials research
J2 - Biomater Res
PY - 2026
DA - 2026/10/27
VL - 30
SP - 0431
SN - 1226-4601
PB - AAAS Science Partner Journal Program
DO - 10.34133/bmr.0431
UR - https://doi.org/10.34133/bmr.0431
LA - en
ER -

CSL-JSON

{
"id": "10.34133/bmr.0431",
"type": "article-journal",
"title": "Glial Scar-Targeted Modification of Hepatocyte Growth Factor-Derived Peptide for Spinal Cord Injury Therapeutic Repair",
"container-title": "Biomaterials research",
"author": [
{
"family": "Wu",
"given": "Yuzhe"
},
{
"family": "Shi",
"given": "Jingwei"
},
{
"family": "Miao",
"given": "Ruize"
},
{
"family": "Xiang",
"given": "Linyi"
},
{
"family": "Zhang",
"given": "Jiacheng"
},
{
"family": "Chi",
"given": "Weiyi"
},
{
"family": "Zhang",
"given": "Yuheng"
},
{
"family": "Geng",
"given": "Yibo"
},
{
"family": "Cai",
"given": "Xiong"
},
{
"family": "Shu",
"given": "Yun"
},
{
"family": "Zhao",
"given": "Jiayi"
},
{
"family": "Zhu",
"given": "Junsheng"
},
{
"family": "Jiang",
"given": "Xiaoqiong"
},
{
"family": "Zhang",
"given": "Haojie"
},
{
"family": "Li",
"given": "Zhenglin"
},
{
"family": "Wang",
"given": "Xiangyang"
},
{
"family": "Sheng",
"given": "Sunren"
},
{
"family": "Zhu",
"given": "Chenchen"
},
{
"family": "Qi",
"given": "Jianjun"
},
{
"family": "Xiao",
"given": "Jian"
},
{
"family": "Zhou",
"given": "Kailiang"
}
],
"container-title-short": "Biomater Res",
"volume": "30",
"page": "0431",
"DOI": "10.34133/bmr.0431",
"PMID": "42947949",
"PMCID": "PMC13710766",
"ISSN": "1226-4601",
"publisher": "AAAS Science Partner Journal Program",
"URL": "https://doi.org/10.34133/bmr.0431",
"language": "en",
"issued": {
"date-parts": [
[
2026,
10,
27
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-022-33184-1 [code]
Single cell atlas of spinal cord injury in mice reveals a pro-regenerative signature in spinocerebellar neurons.
Journal: Nature communications
In common: NCBI GEO GSE172167, other condition, 1 reference
[2] doi:10.1038/s41467-023-40513-5 [code]
Single-cell analysis reveals region-heterogeneous responses in rhesus monkey spinal cord with complete injury.
Journal: Nature communications
In common: NCBI GEO GSE172167, other condition
[3] doi:10.7150/thno.74324
Kruppel-like factor 2 contributes to blood-spinal cord barrier integrity and functional recovery from spinal cord injury by augmenting autophagic flux.
Journal: Theranostics
In common: other condition, author Jian Xiao
[4] doi:10.1038/s41419-024-07062-1
NAD<sup>+</sup>-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer's disease via ATF4-dependent mitochondrial UPR.
Journal: Cell death & disease
In common: author Jian Xiao
[5] doi:10.1021/acsomega.5c03477
Genome-Wide Identification of Microglia-Related RNA-Binding Proteins and Regulated Alternative Splicing in Spinal Cord Injury.
Journal: ACS omega
In common: other condition, 2 references
[6] doi:10.3390/cimb46030133
Melanocortin Derivatives Induced Vascularization and Neuroglial Proliferation in the Rat Brain under Conditions of Cerebral Ischemia.
Journal: Current issues in molecular biology
In common: clinical / translational, 2 references
[7] doi:10.1186/s40035-023-00395-5
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.
Journal: Translational neurodegeneration
In common: 2 references
[8] doi:10.1186/s41232-024-00322-9 [code]
Chronological transitions of hepatocyte growth factor treatment effects in spinal cord injury tissue.
Journal: Inflammation and regeneration
In common: clinical / translational, other condition, 1 reference
[9] doi:10.1111/cns.14468
Electroacupuncture promotes the repair of the damaged spinal cord in mice by mediating neurocan-perineuronal net.
Journal: CNS neuroscience & therapeutics
In common: clinical / translational, other condition, 1 reference
[10] doi:10.1371/journal.pone.0338730 [code]
The effects of 12 weeks of chiropractic spinal adjustments on physiological biomarkers in adults: A pragmatic randomized controlled trial.
Journal: PloS one
In common: clinical / translational, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.